BioHealth News

Emergent Secures $51.9M Contract for Smallpox Vaccine Treatment in U.S. Biodefense Effort

Emergent Secures $51.9M Contract for Smallpox Vaccine Treatment in U.S. Biodefense Effort

GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous…

Read More
Connect Capital and Innovation at the BioHealth Capital Region Investment Conference on September 25, 2025 at US Pharmacopeia, Rockville, MD

Connect Capital and Innovation at the BioHealth Capital Region Investment Conference on September 25, 2025 at US Pharmacopeia, Rockville, MD

The Annual BioHealth Capital Region Investment Conference is the premier destination for discovering emerging companies that are redefining what’s possible in life sciences. Taking…

Read More
Maryland Tech Council Launches Rural Technology Network to Accelerate Rural Innovation

Maryland Tech Council Launches Rural Technology Network to Accelerate Rural Innovation

ROCKVILLE, Md.--(BUSINESS WIRE)--The Maryland Tech Council (MTC), the largest technology and life sciences trade association in the state, today announced the launch of the…

Read More
Reimagining Gene and Cell Therapy: Helen Sabzevari on Precigen’s Breakthroughs in Precision Medicine on BioTalk

Reimagining Gene and Cell Therapy: Helen Sabzevari on Precigen’s Breakthroughs in Precision Medicine on BioTalk

In this episode of BioTalk, Rich Bendis welcomes Dr. Helen Sabzevari, President and CEO of Precigen, to discuss the company’s cutting-edge science in gene…

Read More
Gain Therapeutics Completes Enrollment for Parkinson’s Drug Study

Gain Therapeutics Completes Enrollment for Parkinson’s Drug Study

BETHESDA, Md., June 30, 2025 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…

Read More
George Mason is part of Northern Virginia’s first innovation district, launched with transformational grant from GO Virginia

George Mason is part of Northern Virginia’s first innovation district, launched with transformational grant from GO Virginia

Thanks to a major investment from GO Virginia, Northern Virginia’s first Innovation District is taking shape, laying the groundwork for growth in high-tech industry…

Read More
Pediatrix Appoints Former Children’s National CEO and Former BHI Board Member Dr. Kurt Newman to Board of Directors

Pediatrix Appoints Former Children’s National CEO and Former BHI Board Member Dr. Kurt Newman to Board of Directors

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced that its board of directors has appointed…

Read More
Navigating FDA Disruption: Insights from BHI EIR Kwame Ulmer

Navigating FDA Disruption: Insights from BHI EIR Kwame Ulmer

In a new video feature, BioHealth Innovation’s Entrepreneur-in-Residence (EIR) Kwame Ulmer offers a candid and experienced take on the evolving FDA landscape and its…

Read More
UVA Health: Additional $50 million raised for Manning Institute of Biotechnology

UVA Health: Additional $50 million raised for Manning Institute of Biotechnology

UVA Health has received two anonymous $25 million estate gifts to support the University of Virginia’s Paul and Diane Manning Institute of Biotechnology. The $50…

Read More
Aurinia Reports Strong Early Results for New Autoimmune Drug AUR200

Aurinia Reports Strong Early Results for New Autoimmune Drug AUR200

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced positive results from a Phase 1 single-ascending-dose (SAD) study of aritinercept (AUR200),…

Read More
Apply Now for the BioHealth Capital Region Crab Trap Competition

Apply Now for the BioHealth Capital Region Crab Trap Competition

Applications are now open for the 9th Annual Crab Trap Competition, one of the signature events of BioHealth Capital Region Week 2025, taking place…

Read More
I-Mab Reports Promising Givastomig Phase 1b Results in First-Line Gastric Cancer

I-Mab Reports Promising Givastomig Phase 1b Results in First-Line Gastric Cancer

ROCKVILLE, Md., June 26, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision…

Read More
Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH

Altimmune Announces Positive Topline Results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH

GAITHERSBURG, Md., June 26, 2025 (GLOBE NEWSWIRE) --  Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic…

Read More
Emergent Secures $62.4M Contract Boost for Botulism Antitoxin to Support U.S. Biodefense

Emergent Secures $62.4M Contract Boost for Botulism Antitoxin to Support U.S. Biodefense

GAITHERSBURG, Md., June 23, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a $62.4 million contract modification from the Administration for Strategic…

Read More
BHI and the BioHealth Capital Region Partners Showcase Our Great Assets at BIO 2025 in Boston

BHI and the BioHealth Capital Region Partners Showcase Our Great Assets at BIO 2025 in Boston

The 2025 BIO International Convention brought together over 20,000 life sciences leaders from across the globe. BioHealth Innovation, Inc. (BHI), led by Founder, President,…

Read More